R-enantiomer of 1,2-dioleoyl-3-trimethylammonium-propane chloride + Peptides from HPV-16 E6 and E7
U10-02-11-001
Phase 1 mab completed
Quick answer
R-enantiomer of 1,2-dioleoyl-3-trimethylammonium-propane chloride + Peptides from HPV-16 E6 and E7 for High-risk HPV Infection and Biopsy-proven CIN1 is a Phase 1 program (mab) at PDS Biotechnology Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PDS Biotechnology Corp
- Indication
- High-risk HPV Infection and Biopsy-proven CIN1
- Phase
- Phase 1
- Modality
- mab
- Status
- completed